SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

SUSMED’s Blockchain-Based Clinical Trial System Supports Marketing Authorization

SUSMED says its blockchain-based clinical trial system supported successful marketing authorization for a pharmaceutical product.

Related stories